Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (AU:IPD)
ASX:IPD
Holding AU:IPD?
Track your performance easily
IPD Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.04 - AU$0.16
Previous CloseAU$0.05
Volume243.81K
Average Volume (3M)1.21M
Market Cap
AU$105.22M
Enterprise ValueAU$62.64M
Total Cash (Recent Filing)AU$40.73M
Total Debt (Recent Filing)AU$170.00K
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Aug 28, 2024EPS Estimate
>-AU$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume1,333,258
30 Day Avg. Volume1,211,029
Standard Deviation0.30
R-Squared0.19
Alpha0.00320
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)24.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.11Price Target Upside116.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Impedimed Limited News
PremiumCompany Announcements
Impedimed Director Boosts Shareholding with Major Purchase
PremiumCompany Announcements
Impedimed Director Increases Stake with New Share Acquisition
PremiumCompany Announcements
ImpediMed Limited’s AGM Resolutions Signal Strategic Growth
PremiumCompany Announcements
ImpediMed Limited Aims to Set New Standard of Care
PremiumCompany Announcements
ImpediMed Limited Focuses on Commercial Growth Strategy
PremiumCompany Announcements
ImpediMed Limited Showcases Innovations at Bell Potter
PremiumCompany Announcements
Impedimed Limited Issues Shares to Executives
PremiumCompany Announcements
ImpediMed Limited Presents at Major ConferenceOptions Prices
Currently, No data available
---
Ownership Overview
0.39% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.61% Public Companies and
Individual Investors
IPD FAQ
What was Impedimed Limited’s price range in the past 12 months?
Impedimed Limited lowest share price was AU$0.04 and its highest was AU$0.16 in the past 12 months.
What is Impedimed Limited’s market cap?
Currently, no data Available
When is Impedimed Limited’s upcoming earnings report date?
Impedimed Limited’s upcoming earnings report date is Aug 28, 2024 which is 117 days ago.
How were Impedimed Limited’s earnings last quarter?
Impedimed Limited released its earnings results on Feb 26, 2024. The company reported -AU$0.005 earnings per share for the quarter, the consensus estimate of -AU$0.005 by AU$0.
Is Impedimed Limited overvalued?
According to Wall Street analysts Impedimed Limited’s price is currently Undervalued.
Does Impedimed Limited pay dividends?
Impedimed Limited does not currently pay dividends.
What is Impedimed Limited’s EPS estimate?
Impedimed Limited’s EPS estimate is >-AU$0.01.
How many shares outstanding does Impedimed Limited have?
Impedimed Limited has 2,023,556,800 shares outstanding.
What happened to Impedimed Limited’s price movement after its last earnings report?
Impedimed Limited reported an EPS of -AU$0.005 in its last earnings report, expectations of -AU$0.005. Following the earnings report the stock price went down -7.407%.
Which hedge fund is a major shareholder of Impedimed Limited?
Currently, no hedge funds are holding shares in AU:IPD
---
Impedimed Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.11 (116.09% Upside)
AU$0.11 (116.09% Upside)
Blogger Sentiment
Bullish
AU:IPD Sentiment 85%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $40.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.06%
12-Months-Change
Fundamentals
Return on Equity
-38.30%
Trailing 12-Months
Asset Growth
-31.42%
Trailing 12-Months
Company Description
Impedimed Limited
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. It operates through the Medical, and Test and Measurement segments. The Medical segment supplies non-invasive medical technology products and services to measure, monitor, and manage tissue composition and fluid status using bioimpedance spectroscopy. The Test and Measurement segment offers power precision testing and measuring equipment. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.
---
IPD Stock 12 Month Forecast
Average Price Target
AU$0.11
▲(116.09% Upside)
Technical Analysis
Best Analysts Covering IPD
1 Year
1 Year Success Rate
6/13 ratings generated profit
1 Year Average Return
+1.42%
reiterated a buy rating 4 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +1.42% per trade.
---